American Journal of Cardiology
Volume 77, Issue 5 , Pages 337-343, 15 February 1996

Development of ST-Seament elevation and Q- and R-Wave changes in acute myocardial infarction and the influence of thrombolytic therapy

  • Frits W. Bär, MD

      Affiliations

    • Corresponding Author InformationAddress for reprints: Frits W. Bär, MD, Department of Cardiology, Academic Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.
    • From the Department of Cardiology, Academic Hospital Maastricht, University of Limburg, Maastricht, The Netherlands
    • From the Department of Cardiology, Medizinische Universitätsklinik, Mainz, Germany
  • ,
  • Paul G.A. Volders, MS

      Affiliations

    • From the Department of Cardiology, Academic Hospital Maastricht, University of Limburg, Maastricht, The Netherlands
    • From the Department of Cardiology, Medizinische Universitätsklinik, Mainz, Germany
  • ,
  • Pierre Höppener, MS

      Affiliations

    • From the Department of Cardiology, Academic Hospital Maastricht, University of Limburg, Maastricht, The Netherlands
    • From the Department of Cardiology, Medizinische Universitätsklinik, Mainz, Germany
  • ,
  • Frank Vermeer, MD

      Affiliations

    • From the Department of Cardiology, Academic Hospital Maastricht, University of Limburg, Maastricht, The Netherlands
    • From the Department of Cardiology, Medizinische Universitätsklinik, Mainz, Germany
  • ,
  • Jürgen Meyer, MD

      Affiliations

    • From the Department of Cardiology, Academic Hospital Maastricht, University of Limburg, Maastricht, The Netherlands
    • From the Department of Cardiology, Medizinische Universitätsklinik, Mainz, Germany
  • ,
  • Hein J.J. Wellens, MD

      Affiliations

    • From the Department of Cardiology, Academic Hospital Maastricht, University of Limburg, Maastricht, The Netherlands
    • From the Department of Cardiology, Medizinische Universitätsklinik, Mainz, Germany

Received 14 July 1995; received in revised form 16 October 1995; accepted 17 October 1995.

Abstract 

Sequential electrocardiograms from admission to 36 hours in 358 patients with acute myocardial infarction (AMI) from the Pro-urokinase In Myocardial Infarction trial were assessed. The electrocardiogram was also examined at discharge in 69 of 358 patients. Patients underwent acute angiography, after which angioplasty was performed in most patients with impaired flow. The sum of the ST-segment deviation and Q- and R-wave voltages, and the QRS score were calculated and used for further evaluation. Development of Q waves, loss of R waves, and QRS score were completed within the first 9 hours after onset of AMI and remained stable thereafter. Reperfused patients had earlier stabilization and less severe electrocardiographic (ECG) abnormalities than nonreperfused patients. ST-segment elevation had already stabilized after 5 hours, was unchanged at 36 hours, and had significantly decreased at discharge. No significant ECG and clinical outcome differences were found between the Thrombolysis In Myocardial Infarction trial (TIMI) 2 and TIMI 3 patients. A 23.3% gain in ECG-estimated infarct size was found in the reperfusion group compared with a 12.0% gain in the nonreperfused group (p = 0.08). In summary, as early as 9 hours after onset of AMI, QRS changes were already complete. Thereafter, QRS morphology was stable. Thus, a QRS-based estimation of infarct size can be made as early as 9 hours after AMI. A similar ECG outcome for patients with TIMI 2 and 3 flow was found, which was significantly different from patients with TIMI 0 to 1 flow.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The PRIMI trial was financially supported by Grünenthal, Aachen, Germany.

PII: S0002-9149(97)89360-5

American Journal of Cardiology
Volume 77, Issue 5 , Pages 337-343, 15 February 1996